Research ArticleCancer

PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation

See allHide authors and affiliations

Science Translational Medicine  14 Dec 2016:
Vol. 8, Issue 369, pp. 369ra175
DOI: 10.1126/scitranslmed.aae0348

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article